Friday, June 26, 2009

European Markets Fall, Led By Sanofi, UBS - European Commentary


The European markets fell for the second day on Friday after Sanofi-Aventis slipped following broker downgrades on concern of health risk associated with its Lantus diabetes treatment and UBS tumbled after forecasting a second quarter loss.
In economic news, the U.S. Commerce Department said in its report that personal income jumped 1.4% in May following an upwardly revised 0.7% increase in April. Economists had expected income to rise 0.3% compared to the 0.5% growth originally reported for the previous month.
The U.S. Commerce Department also said that personal spending rose 0.3% in May after coming in unchanged in the previous month. The moderate increase in spending came in line with economist estimates.
Crude for August delivery fell $1.14 to $69.09 a barrel on the New York Mercantile Exchange, by the time the European markets closed, tracking stock markets.
The FTSEurofirst 300 index of pan-European blue chips closed 0.13% lower at 844.59 points, while the narrower DJ Stoxx 50 index fell 0.30% to 2,087.97 points.
Around Europe, the U.K.'s FTSE 100 index fell 0.27% to 4,241.01, while France's CAC 40 index dropped 1.05% to 3,129.73 and Germany's DAX index slipped 0.50% to 4,776.47.
Sanofi-Aventis, France's biggest drugmaker, tumbled 8.1% after JPMorgan Chase downgraded the stock to "neutral" from "overweight" and Morgan Stanley cut its recommendation on the stock to "equal weight" from "overweight."
UBS, Switzerland's second largest bank, dropped 5.4% after the company said it has raised about 3.8 billion Swiss francs selling shares and forecast a loss for the second quarter.
German fertilizer maker K+S AG slid 2.4% after larger rival Potash Corp. of Saskatchewan Inc. cut its second quarter earnings outlook.

Tuesday, June 23, 2009

stock quotes

TradingMarkets 7 Stock Quotes You Need to Know for Wednesday

On Tuesday June 23, 2009, 4:02 pm EDT

Existing Home Sales missed estimates leading to a choppy trading session after Monday's steep sell off. The DJIA gave back another 16.10, the Nasdaq dropped 1.27 and the S&P 500 gained 2.06.
Related Quotes
Symbol Price Change
DRI 31.9 -1.06

LEN 7.82 +0.34

MON 76.16 -3.14

MTH 17.92 +0.54

NKE 53.02 -0.52

ORCL 21.26 +1.39

RMBS 14.90 +0.05

{"s" : "dri,len,mon,mth,nke,orcl,rmbs","k" : "c10,l10,p20,t10","o" : "","j" : ""}
Here are 7 stock Quotes you need to know about for Wednesday.
Oracle (Nasdaq:ORCL - News) beats analysts estimates with a forth quarter EPS of 0.46 cents. The Short Term PowerRating for ORCL is 5.stock quotes
The world's largest owner of full service dining restaurants, Darden Restaurants (NYSE:DRI - News), will host its fourth quarter earnings call at 8:30 AM on Wednesday. EPS increased by 21% to 0.87 cents during the quarter. The Short Term PowerRating for DRI is 5.stock quotes
Nike (NYSE:NKE - News), the sport shoe maker will announce its fourth quarter results, after the close on Wednesday, with analysts estimates of 0.96 cents EPS. The Short Term PowerRating for NKE is 6.stock quotes
Monsanto (NYSE:MON - News) releases third quarter results before the open on Wednesday. The estimate is $1.17/share. The Short Term PowerRating for MON is 5.
Memory chip maker Rambus (Nasdaq:RMBS - News) cuts its second quarter forecast. The Short Term PowerRating for RMBS is 7.stock quotes
Rambus prices $150M offering of senior notes
Rambus prices public offering of 5 percent convertible senior notes due 2014
On Wednesday June 24, 2009, 7:26 am EDT (stock quotes)

LOS ALTOS, Calif. (AP) -- Technology-licensing company Rambus Inc. said Wednesday that it priced a public offering of $150 million 5 percent convertible senior notes due 2014.
The notes can be converted to common stock at an initial price of about $19.31 per share. This would be an approximately 30 percent premium to the common stock's Tuesday closing price of $14.85.
The company said it gave the underwriters a 12-day option to buy up to an additional $22.5 million of the notes to cover overallotments.
Rambus plans to use the offering's proceeds for general corporate purposes, including potential acquisitions, repayment of zero-coupon convertible senior notes due next year and working capital.Rambus prices $150M offering of senior notes
Rambus prices public offering of 5 percent convertible senior notes due 2014
On Wednesday June 24, 2009, 7:26 am EDT (stock quotes)

LOS ALTOS, Calif. (AP) -- Technology-licensing company Rambus Inc. said Wednesday that it priced a public offering of $150 million 5 percent convertible senior notes due 2014.
The notes can be converted to common stock at an initial price of about $19.31 per share. This would be an approximately 30 percent premium to the common stock's Tuesday closing price of $14.85.
The company said it gave the underwriters a 12-day option to buy up to an additional $22.5 million of the notes to cover overallotments.
Rambus plans to use the offering's proceeds for general corporate purposes, including potential acquisitions, repayment of zero-coupon convertible senior notes due next year and working capital.